Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $11.76 billion. The enterprise value is $12.22 billion.
| Market Cap | 11.76B |
| Enterprise Value | 12.22B |
Important Dates
The next confirmed earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Insulet has 70.02 million shares outstanding. The number of shares has increased by 5.33% in one year.
| Shares Outstanding | 70.02M |
| Shares Change (YoY) | +5.33% |
| Shares Change (QoQ) | +14.36% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 103.57% |
| Float | 69.53M |
Valuation Ratios
The trailing PE ratio is 57.04 and the forward PE ratio is 54.49. Insulet's PEG ratio is 3.15.
| PE Ratio | 57.04 |
| Forward PE | 54.49 |
| PS Ratio | 6.78 |
| Forward PS | 5.76 |
| PB Ratio | 15.71 |
| P/FCF Ratio | 315.43 |
| PEG Ratio | 3.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 37.78, with an EV/FCF ratio of 334.92.
| EV / Earnings | 59.26 |
| EV / Sales | 7.20 |
| EV / EBITDA | 37.78 |
| EV / EBIT | 48.74 |
| EV / FCF | 334.92 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 1.93.
| Current Ratio | 3.51 |
| Quick Ratio | 2.36 |
| Debt / Equity | 1.93 |
| Debt / EBITDA | 4.38 |
| Debt / FCF | 38.79 |
| Interest Coverage | 6.93 |
Financial Efficiency
Return on equity (ROE) is 34.40% and return on invested capital (ROIC) is 9.84%.
| Return on Equity (ROE) | 34.40% |
| Return on Assets (ROA) | 8.50% |
| Return on Capital (ROIC) | 9.84% |
| Revenue Per Employee | $565,700 |
| Profits Per Employee | $68,767 |
| Employee Count | 3,000 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.43 |
Taxes
In the past 12 months, Insulet has paid $8.30 million in taxes.
| Income Tax | 8.30M |
| Effective Tax Rate | 3.87% |
Stock Price Statistics
The stock price has decreased by -47.18% in the last 52 weeks. The beta is 1.00, so Insulet's price volatility has been similar to the market average.
| Beta (1Y) | 1.00 |
| 52-Week Price Change | -47.18% |
| 50-Day Moving Average | 173.38 |
| 200-Day Moving Average | 190.25 |
| Relative Strength Index (RSI) | 47.05 |
| Average Volume (30 Days) | 868,856 |
Short Selling Information
The latest short interest is 3.12 million, so 4.45% of the outstanding shares have been sold short.
| Short Interest | 3.12M |
| Short Previous Month | 2.80M |
| Short % of Shares Out | 4.45% |
| Short % of Float | 4.48% |
| Short Ratio (days to cover) | 3.46 |
Income Statement
In the last 12 months, Insulet had revenue of $1.70 billion and earned $206.30 million in profits. Earnings per share was $2.94.
| Revenue | 1.70B |
| Gross Profit | 1.16B |
| Operating Income | 220.00M |
| Pretax Income | 214.60M |
| Net Income | 206.30M |
| EBITDA | 323.60M |
| EBIT | 250.80M |
| Earnings Per Share (EPS) | $2.94 |
Balance Sheet
The company has $704.20 million in cash and $1.42 billion in debt, giving a net cash position of -$711.60 million or -$10.16 per share.
| Cash & Cash Equivalents | 704.20M |
| Total Debt | 1.42B |
| Net Cash | -711.60M |
| Net Cash Per Share | -$10.16 |
| Equity / Book Value | 732.70M |
| Book Value Per Share | 10.46 |
| Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was $145.70 million and capital expenditures -$109.20 million, giving a free cash flow of $36.50 million.
| Operating Cash Flow | 145.70M |
| Capital Expenditures | -109.20M |
| Free Cash Flow | 36.50M |
| FCF Per Share | $0.52 |
Margins
Gross margin is 68.35%, with operating and profit margins of 12.96% and 12.16%.
| Gross Margin | 68.35% |
| Operating Margin | 12.96% |
| Pretax Margin | 12.65% |
| Profit Margin | 12.16% |
| EBITDA Margin | 19.07% |
| EBIT Margin | 14.78% |
| FCF Margin | 2.15% |
Dividends & Yields
Insulet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.33% |
| Shareholder Yield | -5.33% |
| Earnings Yield | 1.79% |
| FCF Yield | 0.32% |
Analyst Forecast
The average price target for Insulet is $250.21, which is 48.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $250.21 |
| Price Target Difference | 48.92% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 16.69% |
| EPS Growth Forecast (5Y) | 22.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Insulet has an Altman Z-Score of 5.02 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.02 |
| Piotroski F-Score | 6 |